Abstract: Background: Ovarian cancer is common malignant tumors but the survival rate has not been improved well for a long time. One of the important reasons is that the current clinical guidelines for treatment still do not solve the problem of patient heterogeneity and drug resistance, which are exactly the key factors affecting the efficacy of chemotherapy. In addition, there are limited research data that can help accurately identify patients' preferred drugs and combination regimen, which fails to meet the needs of individualized treatment. Methods：The objective was used the Hydrogel Embedded Histoculture Drug Sensitivity Test (HDST), to verified its accuracy in predicting the response to chemotherapy in ovarian tumors and evaluate the sensitivity of chemotherapy drugs. Tissue samples of 82 ovarian tumor patients were tested for HDST drug sensitivity and follow-up who were included in randomized study. The consistency of drug sensitivity results and clinical outcomes were analyzed through preliminary study to determine the feasibility of this technology, and then a comprehensive blind study was conducted to evaluate Drug sensitivity.Result: HDST in determining the efficacy of chemotherapy drugs were consistent with the actual clinical efficacy of patients (Kappa=0.535), and the sensitivity, specificity, AUC were 82.14%, 100.00%, 0.911. Single-drug resistance rates of TXL, DOC, CDDP, CBP, Lobaplatin, and VP-16 were 21.95%, 74.39%, 62.20% , 52.44%, 39.02%, 60.98%, respectively. Highest Secondary drug resistance rate of CBP was 44.44%, followed by CDDP and VP-16 (22.22%). TXL’s IR was significantly higher than DOC wherever the location, and Loplatin’s was higher than CDDP (P<0.05). TXL’s IR was higher than VP-16 in primary foci, but VP-16’s was not only higher than DOC, but also CDDP, and similar to the CBP and Lobaplatin in abdominal metastases(P<0.05).Conclusion: HDST can effectively predict the response to existing chemotherapy regimens as new tool to screen individualized treatment for patients. Paclitaxel combined with Lobaplatin regimen may have more advantages in chemotherapy and Etoposide should not be ignored in ovarian tumors.

[Chemotherapy guidance of the drug sensitivity test in vitro in human laryngeal squamous cell carcinoma]

The Impact of Hypoxia Improvement on Laryngeal Squamous Cell Carcinoma Chemotherapy

Research and Exploratory of Chemotherapy Drugs Sensitivity Tests in Liver Cancer

Evaluation of the in Vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer Using the ATP-TCA.

Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations

[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].

[Sensitivity of Two Cell Lines with Acquired Resistance to Gefitinib to Several Chemotherapeutic Drugs].

[Synergistic Effects and Mechanisms of Combined Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapeutic Drugs or Radiotherapy in Killing Laryngeal Squamous Carcinoma Cells in Vitro].

APOPTOSIS AND DRUG SENSITITY TEST OF LUNG CANCER CELL

Study on the chemosensitivity test with TECIA in vitro for the choice of individualized chemotherapy of lung cancer

Study on susceptibility of eight common chemotherapy drug combinations in human cervical carcinoma cell in vitro

STUDY OF CHEMOTHERAPY SENSITIVITY IN TUMOR CELL LINES ASSESSED BY APOPTOSIS

Study of chemosensitivity for human breast cancer cells cultivated in primary generation in vitro

[Progress of Individualized Chemotherapy Guided by Chemosensitivity Test].

[Application of Adenosine Triphosphate Tumor Chemosensitive Assay System to Individual Chemotherapy for Hepatocellular Carcinoma].

Drug Susceptibility Test in Carcinoma of Gallbladder and Cholangiocarcinoma

Sensitivity of different human colorectal tumor cell lines to commonly used chemotherapeutic drugs in vitro

The Apoptotic Pathway of Laryngeal Squamous Carcinoma Cell Line Induced by Combined TRAIL with Chemotherapeutic Drugs or Radiotherapy

Sensitivity Assessment of Chemotherapeutic Agents for Ovarian Tumors Based on Test in Vitro Culture: A Blind Study

Chemosensitivity in vitro of 25 anti-cancer drugs to primary cultured human breast cancer cells

Chemotherapy of Pancreatic Cancers by Drug Sensitivity Test in Vitro